Health

British drug license to treat corona

British drug license to treat corona

British drug license to treat corona

Britain announced today, Thursday, that it has granted a license to use a drug developed by Merck to treat corona.

Last month, Merck and Ridgeback Biotherapeutics applied for emergency use authorization to the US Food and Drug Administration (FDA) for the oral antiviral drug molnupiravir, to treat mild to moderate coronavirus in adults at risk of contracting COVID-19. -XNUMX severe.

The companies are actively working with regulators around the world to apply for emergency use or marketing authorization in the coming months.

The submission is based on positive results from a planned interim analysis from a Phase III MOVe-OUT clinical trial, which evaluated molnoperavir in non-hospitalized adult patients with mild to moderate COVID-19 who were at risk of progressing to severe COVID, or going to the hospital.

What is punitive silence? And how do you deal with this situation?

Ryan Sheikh Mohammed

Deputy Editor-in-Chief and Head of Relations Department, Bachelor of Civil Engineering - Topography Department - Tishreen University Trained in self-development

Related articles

Go to top button
Subscribe now for free with Ana Salwa You will receive our news first, and we will send you a notification of each new not نعم
Social Media Auto Publish Powered By: XYZScripts.com